scholarly article | Q13442814 |
P50 | author | Shawn R Lockhart | Q63185543 |
P2093 | author name string | Elizabeth L Berkow | |
Nancy Chow | |||
Rory M Welsh | |||
P2860 | cites work | Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry | Q36049838 |
Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. | Q36423773 | ||
Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel | Q37664411 | ||
First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia | Q39092138 | ||
Multidrug-resistant endemic clonal strain of Candida auris in India. | Q39092162 | ||
Nosocomial fungemia by Candida auris: First four reported cases in continental Europe. | Q39092317 | ||
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016. | Q39092367 | ||
Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories? | Q42326663 | ||
Candida auris-associated candidemia, South Africa | Q42712931 | ||
Candida auris candidemia in Kuwait, 2014. | Q42787996 | ||
Fitness trade-offs restrict the evolution of resistance to amphotericin B | Q28534687 | ||
Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia | Q28818814 | ||
Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts | Q30561825 | ||
Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital | Q33401940 | ||
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. | Q33634457 | ||
First three reported cases of nosocomial fungemia caused by Candida auris | Q34196357 | ||
New clonal strain of Candida auris, Delhi, India | Q34372060 | ||
Draft Genome Sequence of a Fluconazole-Resistant Candida auris Strain from a Candidemia Patient in India | Q34485537 | ||
Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris | Q34492906 | ||
First hospital outbreak of the globally emerging Candida auris in a European hospital | Q34543358 | ||
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses | Q34547546 | ||
Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology | Q34653849 | ||
Maldi-tof mass spectrometry for microorganism identification | Q34914073 | ||
Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek | Q35586995 | ||
Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. | Q35835357 | ||
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata | Q35867789 | ||
P433 | issue | 13 | |
P921 | main subject | Candida auris | Q26816853 |
P304 | page(s) | 99-103 | |
P577 | publication date | 2017-07-01 | |
P1433 | published in | Clinical microbiology newsletter | Q27720925 |
P1476 | title | Candida auris for the clinical microbiology laboratory: Not your grandfather's Candida species. | |
P478 | volume | 39 |
Q91643627 | Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings |
Q95642098 | Candida auris: From Multidrug Resistance to Pan-Resistant Strains |
Q49988058 | Candida auris: a Review of the Literature. |
Q64136308 | Direct Detection of Emergent Fungal Pathogen Candida auris in Clinical Skin Swabs by SYBR Green-Based Quantitative PCR Assay |
Q58598193 | Epidemiology, clinical characteristics, resistance, and treatment of infections by |
Q58773579 | Fungal Resistance to Echinocandins and the MDR Phenomenon in |
Q51782762 | Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris. |
Q93088245 | Identification of Drug Resistant Candida auris |
Q64084323 | Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen |
Q89288908 | Invasive Candida auris infections in Kuwait hospitals: epidemiology, antifungal treatment and outcome |
Q64039483 | Lactococcus garvieae Endocarditis in a Prosthetic Aortic Valve: A Case Report and Literature Review |
Q58701183 | Limited Mutations Identified in Isolates of Candida auris Directly Contribute to Reduced Azole Susceptibility |
Q55511181 | Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms. |
Q92752608 | Molecular Diagnostics in the Times of Surveillance for Candida auris |
Q94464436 | Nine Things Genomics Can Tell Us About Candida auris |
Q93166142 | Something wicked this way comes: What health care providers need to know about Candida auris |
Q38659451 | Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Healthcare Surface |
Q90019323 | The LUFS domain, its transcriptional regulator proteins, and drug resistance in the fungal pathogen Candida auris |
Q57296241 | The mycoparasitic yeast Saccharomycopsis schoenii predates and kills multi-drug resistant Candida auris |
Q89865425 | The paralogous transcription factors Stp1 and Stp2 of Candida albicans have distinct functions in nutrient acquisition and host interaction |
Q52597955 | Understanding echinocandin resistance in the emerging pathogen Candida auris. |
Q64921062 | Viability of Candida auris and Other Candida Species after Various Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Mass Spectrometry-Based Extraction Protocols. |
Q58128036 | Yeast species-specific, differential inhibition of β-1,3-glucan synthesis by poacic acid and caspofungin |
Q90706869 | [Candida auris: estrategias y retos para prevenir un brote] |